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Identification of KLHL41 Mutations Implicates BTB-Kelch-
Mediated Ubiquitination as an Alternate Pathway
to Myofibrillar Disruption in Nemaline Myopathy
Vandana A. Gupta,1 Gianina Ravenscroft,2 Ranad Shaheen,3 Emily J. Todd,2 Lindsay C. Swanson,1
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Amal Hashem,3 Nicholas D. Manton,8 Francesco Muntoni,9 Kathryn N. North,10 Sarah A. Sandaradura,5
Ichizo Nishino,11 Yukiko K. Hayashi,11 Caroline A. Sewry,9 Elizabeth M. Thompson,12,13 Kyle S. Yau,2
Catherine A. Brownstein,1 Timothy W. Yu,1 Richard J.N. Allcock,14 Mark R. Davis,15
Carina Wallgren-Pettersson,16 Naomichi Matsumoto,17 Fowzan S. Alkuraya,3 Nigel G. Laing,2
and Alan H. Beggs1,*
Nemaline myopathy (NM) is a rare congenital muscle disorder primarily affecting skeletal muscles that results in neonatal death in
severe cases as a result of associated respiratory insufficiency. NM is thought to be a disease of sarcomeric thin filaments as six of eight
known genes whosemutation can cause NM encode components of that structure, however, recent discoveries of mutations in non-thin
filament genes has called this model in question. We performed whole-exome sequencing and have identified recessive small deletions
and missense changes in the Kelch-like family member 41 gene (KLHL41) in four individuals from unrelated NM families. Sanger
sequencing of 116 unrelated individuals with NM identified compound heterozygous changes in KLHL41 in a fifth family. Mutations
in KLHL41 showed a clear phenotype-genotype correlation: Frameshift mutations resulted in severe phenotypes with neonatal death,
whereas missense changes resulted in impaired motor function with survival into late childhood and/or early adulthood. Functional
studies in zebrafish showed that loss of Klhl41 results in highly diminished motor function and myofibrillar disorganization, with
nemaline body formation, the pathological hallmark of NM. These studies expand the genetic heterogeneity of NM and implicate a
critical role of BTB-Kelch family members in maintenance of sarcomeric integrity in NM.Nemaline myopathy (NM) is a rare congenital disorder
primarily affecting skeletal muscle function. Clinically,
NM is a heterogeneous group of myopathies of variable
severity.1,2 The ‘‘severe’’ congenital form of NM presents
with reduced or absent spontaneous movements in utero
leading to severe contractures or fractures at birth and
respiratory insufficiency leading to early mortality. Indi-
viduals with the ‘‘intermediate’’ congenital form of NM
have antigravity movement and independent respiration
at delivery but exhibit delayed motor milestones and
require ventilatory support later in life. The ‘‘typical’’
congenital form of NM usually presents in the neonatal
period or first year of life with hypotonia, weakness, and
feeding difficulties with less prominent respiratory
involvement. In these cases, the disease is usually static1Division of Genetics and Genomics, The Manton Center for Orphan Disease
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ambulant for much of their lives.3 The defining diagnostic
feature of all forms of NM, irrespective of genetic mutation,
is the presence of numerous red-staining rods with Gomori
trichrome stain that appear as rod-shaped electron-dense
structures termed ‘‘nemaline bodies’’ by electron micro-
scopy.4 These nemaline bodies are most frequently cyto-
plasmic; however, the presence of intranuclear rods has
also been reported.5
NM is a genetically heterogeneous condition, and
mutations in eight different genes have been identified
that are associated with dominant and/or recessive forms
of this disease.6–13 Mutations in these genes cause
about 75%–80% of NM cases, suggesting the involvement
of additional unidentified genes in disease etiology.Research, Boston Children’s Hospital, Harvard Medical School, Boston, MA
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Therefore, we performed whole-exome sequencing (WES)
combined, when applicable, with autozygome analysis to
identify mutations in novel genes that underlie the disease
pathology in a cohort of individuals affected with NM
with unknown genetic diagnosis. All subjects were
enrolled following informed consent and research was
conducted according to the protocols approved by the
Institutional Review Boards of the respective institutions
in which these individuals were recruited. Molecular
screening was performed on genomic DNA isolated from
blood samples following standard protocols.
We performed whole-exome or whole-genome
sequencing on a cohort of 60 unrelated NM probands
through Boston Children’s Hospital Gene Partnership
facility. Molecular screening was performed on genomic
DNA isolated from blood samples with standard protocols.
Whole-blood DNA was subjected to solution capture
(SureSelect Human All Exon V4, Agilent Technologies)
to generate barcoded whole-exome sequencing libraries.
Libraries were sequenced on an Illumina HiSeq 2000,
employing paired end reads (100 bp 3 2) to a mean
target coverage of 96.5% and a mean read depth of 71.6.
Alignment, variant calling, and annotation were per-
formed with a custom informatics pipeline employing
BWA,14 Picard, and ANNOVAR15 focusing on rare (<3%
in db SNP135, 1000 Genomes Project Database, and the
[EVS] National Heart, Lung, and Blood Institute Exome
Sequencing Project Exome Variant Server) protein
affecting changes in known and novel human disease
genes. Alternatively, probands for families 203 and 832
were sequenced to greater than 503 depth by Axeq
Technologies on an Illumina HiSeq 2000 following Agilent
SureSelect Exome enrichment with their standard Exome
Sequencing service. Whole-exome sequencing identified
homozygous mutations of KLHL41 in two unrelated
families, suggesting this gene to be a candidate for NM.
All KLHL41 mutations are numbered relative to the
mRNA sequence NM_006063.2 (where position 1 is the
first base of the initiating MET codon) and protein
NP_006054.2. Family 1 is a nonconsanguineous family of
Vietnamese origin. Proband 203-1 is a 16-year-old female
with an intermediate form of NM with a high-arched
palate, dysarthria, and scoliosis who has required
ventilatory support since childhood. WES identified an
apparently homozygous c.103T>C transition in exon 1
resulting in a p.Cys35Arg substitution in this individual
(Figure 1A). This variant was present as heterozygous in
the father and absent in themother. Copy number analysis
in the affected region showed a heterozygous deletion
in the mother and the proband, c.(?_-77)_(*602_?)del.
Therefore, individual 203-1 is compound heterozygous
for a deletion involving a portion of KLHL41 and a
KLHL41 p.Cys35Arg missense change. The second pro-
band (832-1), who is adopted of Russian origin, is ambu-
lant at age 12 and exhibits the typical congenital form of
NM. WES identified a homozygous deletion of one base
and an insertion of four bases c.459delinsACTC in theThe American Jouproband resulting in a single amino acid insertion,
p.Ser153_Ala154insLeu in the protein (Figure 1A).
Whole-exome sequencing in probands with severe
NM in Australian and Saudi Arabian cohorts resulted in
identification of KLHL41 mutations in two further fam-
ilies. The first (6462) is a consanguineous family of Persian
origin from Afghanistan with one child (D12-203) affected
with severe NM and four unaffected children (see Figure S1
available online). Homozygosity mapping was performed
on the proband with the Illumina HumanCytoSNP-12
array, and the only known NM loci found within homo-
zygous regions were CFL2 (MIM 601443) and NEB
(MIM 161650); however, both were excluded following
Sanger sequencing, as was ACTA1 (MIM 102610), which
is the most common cause of simplex NM cases. WES of
DNA from proband D12-203 was performed at the Lotter-
ywest Sate Biomedical Facility Genomics Node, Royal
Perth Hospital, Western Australia.13 WES identified 453
heterozygous or homozygous variants. Application of the
homozygosity data to the list of candidates reduced this
to seven candidate variants. Two of these seven candidate
variants were in skeletal-muscle-specific genes and of
these the most likely candidate was a homozygous
deletion within KLHL41 (chr2: 170382132–170382139;
c.1748_1755delAAGGAAAT, p.Lys583Thrfs*7) (Figure 1A).
The deletion was confirmed by Sanger sequencing. Both
parents and two unaffected siblings were heterozygous
for the deletion, and two further unaffected siblings were
homozygous for the normal allele.
Family 12DG1177, from a Saudi Arabian cohort is con-
sanguineous (Figure S1). The male proband (12DG1177-
1) was a newborn with severe hypotonia, dislocation of
hips and knees, and facial dysmorphism in the form of
micrognathia and cleft palate. There was a positive family
history of two previous sibs who died of unknown causes
soon after birth, as well as three healthy living sibs. The
proband died of cardiorespiratory arrest shortly after
intubation at less than 24 hr of age. Exome capture was
performed with TruSeq Exome Enrichment kit (Illumina)
as described earlier.16 Only novel coding and splicing
homozygous variants within the autozygome of the
affected individual were considered. After filtering, 8,653
homozygous, coding, or splice variants were present,
and autozygosity mapping, dbSNP, and analysis of 240
control Saudi exomes finally led to the identification of
18 candidate variants. The only truncating change was a
single base deletion in KLHL41 (c.641delA). This deletion
was present in the coding region of exon 1 of KLHL41
resulting in the frameshift change p.Asn214Thrfs*14
(Figure 1A).
Subsequent screening for KLHL41 mutations in 116
individuals affected with severe, intermediate, or typical
congenital forms of NM in the Boston and Australian
NM Cohorts by Sanger sequencing identified a further
family (D10-236) with compound heterozygous muta-
tion (c.581_583delAAG, p.Glu194del and c.1238C>T,
p.Ser413Leu) in proband. This individual is of Chinesernal of Human Genetics 93, 1108–1117, December 5, 2013 1109
Figure 1. Overview of Mutations in KLHL41 and Their Effect on Protein Structure
(A) Schematic representation of mutations in KLHL41. Boxes represent exons 1–6. Conserved domains of KLHL41 are indicated as
follows: BTB (blue), BACK (red), and Kelch repeats (green). The BTB and BACK domains are encoded by exon 1 and the five Kelch repeats
are encoded by exons 1–6.
(B and C) Crystal structures of the BTB-BACK domain of human Kelch-like protein (KLHL11) in complex with CUL3 (Protein Data Bank
code 4AP2) (B) and the Kelch domain of rat KLHL41 (PDB code 2WOZ) (C). a helices, b strands, and loops are drawn as ribbons, arrows,
and threads, respectively. The squared areas correspond to the close-up views in the insets. In (B), the BTB and BACK domains are colored
pink and green, respectively, whereas CUL3 is colored yellow, except that Ile96, Ala224, and Glu264 (Cys35, Ala154, and Glu194 in
human KLHL41, respectively) are colored red. The side chains of these residues and Glu263 (Glu193 in human KLHL41) are shown
as sticks with the indications of amino acid numbers for human KLHL11 and those for human KLHL41 in parentheses. Side chains
involved in hydrophobic cores around Ile96 and Ala224 are drawn in van der Waal’s representation. In (C), the Kelch domain is
color-coded to indicate each Kelch repeat, except that Ser413 is colored red. The side chain of Ser413 is shown as sticks. Molecular
structures are drawn with PyMOL.
(D) Predicted free energy changes upon the substitutions of KLHL41 with FoldX software.origin and exhibited the typical congenital form of NM.
The detailed clinical features of affected individuals with
mutations identified in KLHL41 are presented in Table 1.
Overall, WES and Sanger sequencing resulted in identifi-
cation of seven different mutations in Kelch-like family
member 41 (KLHL41), previously known as KBTBD10,
sarcosin, or KRP1, in affected NM individuals from five
unrelated families (Figure 1A). Muscle histology was
typical for NM: biopsies from probands of three different
families (D12-203, 832-1, and 10-236) exhibited abnormal
Gomori trichrome staining with presence of sarcoplasmic1110 The American Journal of Human Genetics 93, 1108–1117, Decerods that varied from numerous small rods to fewer
large rods in multiple myofibers (Figure 2A). No intranu-
clear rods or cores were seen. The missense changes
identified in KLHL41 are predicted to be pathogenic by
polyphen, SIFT and pMUT and the mutated amino-acid
residues are conserved in all representative species during
evolution (Figure S2). The neighboring areas surrounding
the sites of insertion or deletion are also relatively
conserved, suggesting a structural or functional require-
ment for the altered amino acid residues (Figure S2).
Sequencing of family members revealed that KLHL41mber 5, 2013
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The American Joumutations showed a segregation pattern compatible with
a recessive mode of inheritance in all families (Figure S1).
Severe phenotypes associated with genetic null mutations
and intermediate or typical congenital forms with muta-
tions that should results in presence of residual protein,
suggests a phenotype-genotype correlation in individuals
affected with KLHL41 mutations.
KLHL41 belongs to the family of BTB-Kelch domain-
containing proteins.17–20 Mutations in two other members
of this family, KBTBD13 (MIM 613727), and most recently
KLHL40 (MIM 615430), have been associated with a
clinically distinct form of congenital myopathy exhibiting
nemaline bodies, as well as multiminicores and severe NM,
respectively.12,13 To evaluate the impacts of the KLHL41
mutations on the protein structure, we mapped them
onto the crystal structures of the BTB-BACK domain of
human KLHL11 in complex with human CUL3, a subunit
of E3 ubiquitin ligases, (PDB code 4AP2)21 and the Kelch
domain of rat KLHL41 (PDB code 2WOZ),22 analogous to
those domains of human KLHL41. The Cys35 side chain
is involved in a hydrophobic core of the BTB domain,
which makes van der Waals contacts with Phe54 of
Cul3 (Figure 1B). The p.Cys35Arg substitution present
in affected individual 203-1 would likely destabilize the
hydrophobic core and thereby impair the interaction
with Cul3. This was supported by the FoldX result, in
which free energy change upon the p.Cys35Arg substitu-
tion was predicted to be over 4 kcal/mol, which can be
interpreted as considerable destabilization of a protein
structure (Figure 1D; Figure S3).23 In proband 832-1, a
Leu residue is inserted between the amino acid positions
153 and 154 in the center of a helix, in which several res-
idues are involved in a hydrophobic core of the BACK
domain (Figure 1B). This amino acid insertion is likely to
destabilize the BACK domain fold. In proband D10-236,
the p.Ser413Leu substitution was mapped to a loop region,
which is located near the substrate-binding region of
the Kelch repeat 2 (Figure 1C; Figure S1B). A FoldX
calculation predicted that the p.Ser413Leu substitution
would have minimal effect on stability of the Kelch
domain (Figure 1D). The effect of Glu194 deletion at the
N-terminal end of an a helix can be compensated by
the presence of Glu193 located in the loop (Figure 1B).
Nonetheless, it cannot be excluded that the p.Ser413Leu
and p.Glu194del changes alter the protein solubility
or aggregate tendency and/or impair substrate binding.
The conserved nature of the mutated KLHL41 domains,
as well as the potential role of the mutations in disrupting
those structural domains, supports the likely pathogenicity
of these mutations.
The localization of KLHL41 in skeletal muscles was
investigated by immunofluorescence of mouse FDB
cultured myofibers and human skeletal muscle cryosec-
tions. Immunofluorescence with two different antibodies
against N-terminal (Sigma, AV38732) and C-terminal parts
of human KLHL41 (Abcam, ab66605) was performed, and
z stacks were acquired by confocal microscopy as describedrnal of Human Genetics 93, 1108–1117, December 5, 2013 1111
Figure 2. Muscle Pathology and Expression of KLHL41 Levels and Localization in Muscle of Affected Individuals
(A) Light microscopy of Gomori trichrome stained skeletal muscle from affected individuals with KLHL41mutations show cytoplasmic
nemaline bodies (top panel). Electron microscopy of affected muscles reveals rods of variable frequency and size and severe myofibrillar
disarray (bottom panels). (Scale bars represent 2 mm). Affected individuals’ IDs are indicated at top.
(B) Immunoblotting analysis of KLHL41 levels in affected and unaffected muscles. A decrease in protein levels was observed in individ-
uals with KLHL41mutations in comparison to normal control muscles. Immunoblotting with sarcomeric actin or Coomassie staining of
myosin heavy chain showed no abnormal accumulation of sarcomeric proteins in affected muscles. Immunostaining for GAPDH was
used for loading controls. Lanes: F:23, 23 week control fetus; F:30, 31 week control fetus; 6-month-old control baby, C1–C5 are normal
age-matched control muscles.
(C) Immunofluorescence for KLHL41 in control and affected individual muscle biopsies showed highly reduced levels of KLHL41 in
longitudinally oriented (left) or transverse sections (right) of skeletal muscles from affected individuals. Scale bars represent 50 mm.
1112 The American Journal of Human Genetics 93, 1108–1117, December 5, 2013
previously.24 Immunofluorescence with both antibodies
resulted in similar staining patterns; however, due to lower
background staining, the C-terminal antibody was used
for further studies. Costaining with sarcomeric markers
in longitudinal planes showed that KLHL41 staining
predominated over the I-bands of the sarcomere and at
perinuclear regions in human biopsies (Figure 2C) and
murine cultured myofibers (Figure S4). Analysis of trans-
verse sections of myofibers from control human biopsies
revealed KLHL41 staining in a ring pattern around the
myofibrils, generally colocalizing with ryanodine receptors
(RYR1), which are a marker of the sarcoplasmic reticulum
(Figure S5). Together, these observations suggest that
KLHL41 localizes over (but not within) I bands, likely in
association with the terminal cisternae of the sarcomplas-
mic reticulum (SR) and longitudinal vesicles of the SR
present in the I-band area at the triadic regions (Figure S4).
Colocalization studies with the ERmarker protein disulfide
isomerase (PDI) in myofibers and skeletal muscles further
confirmed the localization of KLHL41 in SR-ERmembranes
(Figures S4). This overall localization pattern is most
consistent with localization to the endoplasmic reticulum
(ER) around myonuclei and to microdomains of the SR
with ER characteristics.25 Previous studies suggested that
the closely related NM protein, KLHL40, localized at A-
bands,13 but double label immunofluorescence studies of
both longitudinal and transverse sections here reveal that
it appears colocalized with RYR1, around but not within
the myofibrils in cultured myofibers and human skeletal
muscles in a pattern overlapping, but not identical to,
that of KLHL41 (Figures S4 and S5). These associations of
proteins whose defects cause NM with the ER/SR contrasts
with previously known NM proteins, all of which are
sarcomeric thin filament components, with the exception
of KBTBD13 whose localization is not well known.
In mouse tissues, immunoblotting detected KLHL41
in skeletal muscle and diaphragm (Figure S6). In cultured
murine C2C12 cells, KLHL41 levels increased during
differentiation to myotubes (Figure S6). Immunoblotting
of affected skeletal muscle extracts revealed greatly reduced
levels of KLHL41 in individuals with KLHL41 mutations
(Figure 2B) and immunofluorescence microscopy of
affected individuals’ skeletal muscles also showed that
KLHL41 levels were greatly reduced in their myofibers
(Figure 2C).
Cell culture studies have shown that KLHL41 interacts
with nebulin, N-RAP (Nebulin-related anchoring protein),
and actin in skeletal muscle and promotes the assembly
of myofibrils.26 KLHL41 regulates skeletal muscle dif-
ferentiation as overexpression or knockdown inhibited
C2C12 myoblast differentiation.27 Knockdown of Klhl41
in cultured cardiomyocytes resulted in sarcomeric dis-
organization with thickening of Z-lines as seen in NM.28
However, the exact functions of KLHL41 in disease
pathology are unknown. Recent studies have identified
mutations in two other closely related family members
KBTBD13 and KLHL40 as causes of NM suggesting theThe American Joucrucial requirement for several Kelch family proteins in
skeletal muscle function.12,13 To investigate the functional
role of KLHL41 in vertebrate skeletal muscle development,
we employed zebrafish as a model system. Zebrafish have
two duplicated orthologs (klhl41a and klhl41b) that share
~80% similarity with KLHL41. Zebrafish whole-mount
in situ hybridization was performed to study the spatio-
temporal expression of these genes during zebrafish
development as described previously.29 Specifically, RNA
probes specific for each Klhl41 gene were generated
by amplification of the 30 UTRs from a cDNA library of
2 day postfertilization (dpf) zebrafish embryos, followed
by in vitro transcription to generate digoxigenin-labeled
antisense transcripts (primer sequences are provided in
Table S1). Whole-mount in situ hybridization showed
ubiquitous expression of klhl41a during early development
at 1 dpf, but by 2 dpf, klhl41a transcripts were virtually
undetectable in the major axial skeletal muscles. In
contract, klhl41b expression was predominantly seen in
striated muscles, and strong expression in heart and
skeletal muscles was observed throughout zebrafish devel-
opment to at least 5 dpf (Figure 3A).
The effect of KLHL41 deficiency in zebrafish was studied
by knocking down the Klhl41 genes with antisense
morpholinos. Two independent morpholinos targeting
an exon-intron spice site and translational start site were
designed for both genes (morpholino sequences are
provided in Table S2). As initial experiments with both
morpholinos for each transcript resulted in similar pheno-
types, we performed the remainder of our studies with
the splice-site morpholinos (7 ng). klhl41a morphants
exhibited leaner bodies, smaller eyes, and pericardial
edema as seen in other myopathy models (n ¼ 65–110)
(Figure 3B).30,31 Examination of 3 dpf morphants with
polarized light showed reduced birefringence in axial
skeletal muscles suggesting disorganized skeletal muscle
structure (Figure 3B; Figure S7). Knockdown of klhl41b
resulted in reduced birefringence without any other signif-
icant abnormalities (n ¼ 82–132). Targeting both klhl41a
and klhl41b (7 ng each) resulted in curved bodies with a
30% reduction in size along with small eyes and pericardial
edema (n ¼ 89–103), compared to fish injected with con-
trol morpholino (14ng). klhl41a morphant fish die by 3
dpf while klhl41b morphants typically did not survive
past 5 dpf. Knockdown of both genes was lethal by 3 dpf.
Double knockdown fish exhibited severely disorganized
muscle (measured by reduced birefringence) compared to
controls and either of the single knockdowns. RT-PCR
and immunoblotting confirmed the knockdown of
klhl41a and klhl41b transcripts and a reduction in protein
levels (Figures 3C and 3D). Overexpression of human
KLHL41 mRNA in the double morphants resulted in a
significant increase in the number of surviving fish
with normal birefringence suggesting the specificity of
morpholino injections and demonstrating the ability of
this single evolutionary ortholog to complement both ze-
brafish genes (Figure 3E). Behavioral characterization of 3rnal of Human Genetics 93, 1108–1117, December 5, 2013 1113
Figure 3. Characterization and Knockdown of Zebrafish Orthologs of KLHL41
(A) In situ hybridization of the zebrafish Klhl41 genes shows early expression during myogenesis in developing somites (11 hr after
fertilization). Klhl41a is expressed in brain, eyes, and muscle at 1 dpf. Later in development expression is largely restricted to brain
and heart (2 dpf), although low levels of expression in axial slow skeletal myofibers cannot be excluded due to limited sensitivity of
the assay. Klhl41b expression is localized to skeletal muscle and heart at all developmental stages (1–2 dpf).
(B) Knockdown of Klhl41 genes in zebrafish using antisense morpholinos results in myopathic changes. Live microscopy of zebrafish
embryos at 3 dpf reveals leaner and smaller bodies in comparison to wild-type (WT) fish. Under polarizedmicroscopy, zebrafish embryos
(legend continued on next page)
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Figure 4. Loss of klhl41 Function in
Zebrafish Recapitulates the Disease Pa-
thology of Human Nemaline Myopathies
(A) Whole-mount staining of 3 dpf zebra-
fish embryos with phalloidin showed
extensive myofibrillar disarray of myo-
fibers in klhl41 morphant fish (scale bar
represents 2 mm). Three dpf embryos
fixed in 4% paraformaldehyde were
incubated with phalloidin (Invitrogen,
A12380, 1:40) overnight at 4C. Skeletal
muscles of klhl41-deficient embryos were
smaller and exhibited an overall reduction
of myofibrillar organization (inset, high
magnification).
(B) Electronmicroscopy of klhl41-deficient
skeletal muscle revealed thickened Z-lines
in klhl41a or klhl41b morphants. In
addition, skeletal muscle of double
knockdown fish contained electron dense
bodies, reminiscent of nascent nemaline
rods (arrowhead, nemaline bodies like
structures; arrow, thickened Z-lines) (scale
bar represents 1 mm).dpfmorphant fish, knocked down for either or both Klhl41
genes, using the touch-evoked response assay showed
significantly diminished motility in comparison to control
fish (WT fish: 5.74 5 0.98 cm/0.1 s;
klhl41a: 1.32 5 0.61 cm/0.1 s; klhl41b: 2.00 5 0.49 cm/
0.1 s; klhl41ab: 0.735 0.39 cm/0.1 s), suggesting a signifi-
cant degree of overall muscle weakness (Movies S1, S2, S3,
and S4).32 To visualize abnormalities in sarcomeric architec-exhibit a reduction in birefringence in morphant fish, quantified in ImageJ as described (W
3.0%; klhl41b: 31% 5 8.2%; klhl41ab: 16% 5 4.2%). Double knockdown fish show a mo
single morphants.
(C) RT-PCR analysis showed knockdown of normal transcripts in the morphant fish.
(D) Immunoblot analysis showed reduction in Klhl41 levels in klhl41a, klhl41b, and k
both klhl41a and klhl41b and therefore show immunoreactibility to the other gene in th
in double morphants.
(E) Overexpression of human KLHL41 mRNA restores the skeletal muscle phenotypes o
suggesting morpholino specificity. The mRNA concentration used to rescue were as follows:
(60 pg of each).
The American Journal of Human Geneticture, whole-mount staining of mor-
phant fish and control zebrafish em-
bryos was performed with phalloidin
to stain the actin-thin filaments.
Although well-organized myofibrillar
striations (i.e., sarcomeres) were
observed, themyofibrils inklhl41mor-
phants tended to be thinner and were
highly disorganized relative to control
fish (Figure 4A). Themyofibrilar disor-
ganization in klhl41 morphants was
also evident by evaluation of ultrathin
toluidine blue sections of control and
morphant fish (Figure S7). The main
diagnostic feature of NM is the pres-
ence of nemaline rods with or without
Z-line streaming in skeletal muscle.Ultrastructural examination of zebrafish skeletal muscle
by electron microscopy showed Z-line thickening in
both klhl41a and klhl41bmorphant fish (Figure 4B). Knock-
down of both klhla and klhl41b resulted in the presence
of numerous electron-dense structures, reminiscent of
small or nascent nemaline bodies, in addition to Z-line
thickening (Figure 4B). Given the differences in temporal
expression of klhl41a (early embryogenesis) and klhl41bT controls: 100% 5 5.9% klhl41a: 23% 5
re severe skeletal muscle phenotype than
lhl41ab fish. Klhl41 antibody recognizes
e single morphants that is highly reduced
f klhl41a/b single and double morphants
klhl41a (50 pg), klhl41b (75 pg), klhl41aþb
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(maintained later in development), and the high degree of
structural and functional conservation (both are rescued
by the single human transcript), it is likely that increased
severity of klhl41a morphants is due to this being the pre-
dominant embryonic isoform at the early stages targeted
by morpholino injections.
Extensive skeletal muscle disorganization associated
with sarcomeric abnormalities in morphant fish points
toward a function of KLHL41 in skeletal muscle develop-
ment and maintenance. Mutations affecting the closely
related BTB-Kelch family member KLHL40 have recently
also been reported to cause nemaline myopathy.13 While
KLHL40 mutations resulted in a severe clinical presen-
tation in most of the affected individuals, KLHL41 abnor-
malities are associated with a spectrum of phenotypes
from severe with neonatal death, to survival into late
childhood. However, no significant differences were seen
in skeletal muscle pathology. KLHL40 contains a putative
nuclear localization sequence (NLS) and is expressed
throughout muscle differentiation, whereas KLHL41 lacks
NLS and is expressed in late differentiation (Figure S8).13
KLHL41 and many other BTB domain-containing Kelch
family members are known to interact with Cul3 ubiquitin
ligase to form functional ubiquitination complexes with
proteins targeted for degradation.21,33 KLHL41, which
has been shown to interact with nebulin,34 is now the
third BTB-Kelch family member to be identified as a cause
of NM when mutated. We hypothesize that improper
surveillance and degradation of aberrant thin-filament
proteins might explain the convergent pathological and
clinical phenotypes associated with mutations of thin
filament and BTB-Kelch family member genes in NM.Supplemental Data
Supplemental Data include eight figures, two tables, and four
movies and can be found with this article online at http://www.
cell.com/AJHG/home.Acknowledgments
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